Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Musim Mas Group is a leading global integrated palm oil corporation headquartered in Singapore, with a significant presence in the life sciences sector through its specialized oleochemicals and functional ingredients. The company operates the Novel IDEAS Center, an R&D and innovation facility located in the Singapore Science Park, where it develops advanced solutions for the pharmaceutical, nutraceutical, and personal care industries. Its product portfolio includes high-purity medium-chain triglycerides (MCTs) under the MASESTER brand, natural Vitamin E (tocotrienols) under the Vitrenol brand, and pharmaceutical-grade glycerine. Musim Mas serves as a critical supplier to global pharmaceutical companies, providing excipients and active ingredients used in drug formulations, clinical nutrition, and specialized health supplements. The group is recognized for its commitment to sustainability and innovation, maintaining a robust pipeline of over 100 R&D projects focused on healthier and more sustainable ingredient solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mas Group.